Skip to content
POM-V Prescription Required Companion Animal

Vetivex 11 (Hartmann's) Solution for Infusion for Cattle, Horses, Dogs and Cats

Active ingredients: Calcium Chloride Dihydrate, Potassium Chloride, Sodium Chloride, Sodium Lactate

Form

Solution

Species

Cats Cattle Dogs Horses

Manufacturer

Dechra Regulatory B.V.

VMD MA No.

50406/5045

What it's used for

gastrointestinal disease or shock. AN: 03510/2024 & 03512/2024

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Calcium Chloride Dihydrate +...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Vetivex 11 (Hartmann's) Solution for Infusion for Cattle, Horses, Dogs and Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

gastrointestinal disease or shock.
AN: 03510/2024 & 03512/2024
The volume and rate of infusion will depend upon the clinical condition, existing
deficits of the animal, maintenance needs and continuing losses.
Generally, aim to correct hypovolaemia by 50 % initially (ideally over 6 hours but
faster if necessary) and reassess by clinical examination.
Deficits are generally in the range of 50 ml/kg (mild) to 150 ml/kg (severe). An
infusion rate of 15 ml/kg/hour is recommended in the absence of shock (range 5-75
ml/kg/hour).
In shock, high initial infusion rates, up to 90 ml/kg/hour, are needed. High infusion
rates should not be continued for longer than 1 hour unless renal function and urine
output are restored. The maximum infusion rate should be decreased in the presence
of cardiac, renal and pulmonary disease.
AN: 03510/2024 & 03512/2024
Do not use in animals with:
- hyperkalaemia
- hypercalcaemia
- hypernatraemia
- hyperlactataemia
- hyperhydration
- metabolic alkalosis
- oedema (hepatic, renal, or cardiac)
- Addison’s disease.
Cattle, horses, dogs and cats:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Eczema, Skin lesion
Allergic oedema, Urticaria
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
None.

Special precautions for safe use in the target species:
Do not use unless the solution is clear, free from visible particles, and the container is
undamaged.
A risk of thrombosis with intravenous infusion should be considered.
Maintain aseptic precautions.
This veterinary medicinal product should be warmed to approximately 37 °C prior to
the administration of large volumes, or if the administration rate is high, in order to
avoid hypothermia.
This veterinary medicinal product does not contain an antimicrobial preservative. It is
intended for single use only and any unused contents should be discarded.
Use of this solution requires monitoring of the clinical and physiological status of the
animal especially in cases of:
- severe renal impairment
- cardiac impairment
- sodium retention with oedema
- treatments with corticosteroids and their derivatives.
This veterinary medicinal product should be used with caution in animals with cardiac
or renal impairment as sodium overload may occur. It should be noted that sodium
excretion may be impaired post-surgery/trauma.
Monitor serum potassium and serum calcium in treated animals, particularly
potassium levels in cases at risk of hyperkalaemia, such as during chronic renal
failure.
In animals with hepatic impairment, the veterinary medicinal product may not produce
its alkalising action since lactate metabolism may be altered.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Not applicable.
Special precautions for the protection of the environment:
Not applicable.
AN: 03510/2024 & 03512/2024
This veterinary medicinal product is incompatible with methylprednisolone, and
sodium lactate or sodium bicarbonate intravenous infusions.
Interactions linked to calcium.
In case of concomitant blood transfusion, the veterinary medicinal product should not
be administered with the blood in the same infusion set due to the risk of clotting.
This veterinary medicinal product contains calcium. Do not add drugs to this solution
that may bind (chelate) to calcium.
Do not store above 25 C.
Do not freeze.
Meat and offal: zero days.
Milk: zero hours.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.